Tag: US44984F4019

INVO Fertility Announces Second Quarter 2025 Financial Results

SARASOTA, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition and operation of fertility clinics and related businesses and technologies, today announced second quarter 2025 financial results.

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Phone

This field is for validation purposes and should be left unchanged.

HomeTagsUS44984F4019

CALX EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Calix (CALX) Investors of Securities Class Action Lawsuit Deadline on July 27, 2026

FREELANDER 8 Makes First Public Appearance Ahead of Official Abu Dhabi Launch

Hozpitality Celebrates Hospitality Excellence at the Middle East Chef Excellence Awards, F&B Excellence Awards and Leaders Powerlist 2026

Tag: US44984F4019

INVO Fertility Announces Second Quarter 2025 Financial Results

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us